Document Detail

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.
MedLine Citation:
PMID:  2061979     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine whether clinical selection for thrombolytic therapy for acute myocardial infarction results in a skewed population for subsequent adverse cardiovascular events.
DESIGN: A comparison of the clinical features of the patients in the Survival and Ventricular Enlargement Study who either had or had not received thrombolytic therapy was conducted in both univariate and multiple logistic regression analyses.
SETTING: Hospitalized patients experiencing acute myocardial infarction from 112 broadly representative, private, academic, and government hospitals in the United States and Canada.
PATIENTS: All patients in the Survival and Ventricular Enlargement Study had had a recent myocardial infarction (less than 16 days) and had a left ventricular ejection fraction of 40% or less.
INTERVENTION: Thrombolytic therapy was administered to 733 patients and was not given to 1498.
MAIN OUTCOME MEASURES: The comparisons with respect to use of thrombolytic therapy were formulated after the completion of enrollment and indicated that the majority of patients did not receive thrombolytic therapy.
RESULTS: The 1498 (67.1%) patients who did not receive thrombolytic therapy were at higher risk (older age, lower functional capacity, greater likelihood of a history of prior myocardial infarction, angina, diabetes, and hypertension) for subsequent cardiovascular events and, as anticipated, were more likely to have concomitant gastrointestinal and neurological diseases. A multiple logistic regression analysis indicated that older age, prior myocardial infarction, impaired functional status, employment status, diabetes, and neurological diseases were predictors of use of thrombolytic therapy.
CONCLUSION: Although the Survival and Ventricular Enlargement Study population was selected for left ventricular dysfunction, the majority of patients who currently are judged clinically as unsuitable for thrombolytic therapy have a higher risk for adverse cardiovascular events.
M A Pfeffer; L A Moyé; E Braunwald; L Basta; E J Brown; T E Cuddy; G R Dagenais; G O Flaker; E M Geltman; B J Gersh
Related Documents :
3527809 - Significance of infarct site and methylprednisolone on survival following acute myocard...
1899409 - Determinants of recurrent ischaemia and revascularisation procedures after thrombolysis...
9593569 - Thrombolysis for acute myocardial infarction.
9812079 - Prospective echocardiographic analysis of progressive obstruction of the proximal pulmo...
2061979 - Selection bias in the use of thrombolytic therapy in acute myocardial infarction. the s...
17660059 - Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
22090349 - Using biomaterials to improve the efficacy of cell therapy following acute myocardial i...
7121779 - Overall management of vascular lesions considered treatable with extracranial-intracran...
1100239 - Coronary arteriography: indications and pitfalls.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JAMA     Volume:  266     ISSN:  0098-7484     ISO Abbreviation:  JAMA     Publication Date:    1991 Jul 24-31
Date Detail:
Created Date:  1991-08-06     Completed Date:  1991-08-06     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  528-32     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Captopril / therapeutic use*
Middle Aged
Myocardial Infarction / drug therapy*,  mortality,  physiopathology
Regression Analysis
Selection Bias
Stroke Volume
Thrombolytic Therapy*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
Next Document:  Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiologic...